Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (491-500 of 999) with videos related to

Pageof 100
Sort By:
American Heart Journal|November 5, 2003
Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS)Christie M Ballantyne, Michael A Blazing, Donald B Hunninghake, et al.
Texas Heart Institute Journal|January 22, 2009
Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) studyVijay Nambi, Alanna C Morrison, Ron C Hoogeveen, et al.
American Heart Journal|May 17, 2011
Peripheral artery disease, biomarkers, and darapladibJeffrey S Berger, Christie M Ballantyne, Michael H Davidson, et al.
The American Journal of Medicine|June 15, 2015
Implications for Ezetimibe Therapy Use Based on IMPROVE-IT CriteriaSalim S Virani, Julia M Akeroyd, Vijay Nambi, et al.
Clinical Chemistry|April 27, 2011
Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities studySunil K Agarwal, Christy L Avery, Christie M Ballantyne, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 1994
Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survivalC M Ballantyne, E A Mainolfi, J B Young, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) studyYuhree Kim, Kunihiro Matsushita, Yingying Sang, et al.
Journal of the American College of Cardiology|October 11, 1991
Lipoprotein(a) and apolipoprotein changes after cardiac transplantationJ A Farmer, C M Ballantyne, O H Frazier, et al.
Diabetes, Obesity & Metabolism|February 27, 2023
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort studySuzanne V Arnold, James A de Lemos, Luke Zheng, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2024
Ancestrally diverse genome-wide association analysis highlights ancestry-specific differences in genetic regulation of plasma protein levelsChloé Sarnowski, Jianzhong Ma, Ngoc Quynh H Nguyen, et al.
Pageof 100

Showing results (491-500 of 999) with videos related to

Sort By:
Pageof 100
American Heart Journal|November 5, 2003
Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS)Christie M Ballantyne, Michael A Blazing, Donald B Hunninghake, et al.
Texas Heart Institute Journal|January 22, 2009
Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) studyVijay Nambi, Alanna C Morrison, Ron C Hoogeveen, et al.
American Heart Journal|May 17, 2011
Peripheral artery disease, biomarkers, and darapladibJeffrey S Berger, Christie M Ballantyne, Michael H Davidson, et al.
The American Journal of Medicine|June 15, 2015
Implications for Ezetimibe Therapy Use Based on IMPROVE-IT CriteriaSalim S Virani, Julia M Akeroyd, Vijay Nambi, et al.
Clinical Chemistry|April 27, 2011
Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities studySunil K Agarwal, Christy L Avery, Christie M Ballantyne, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 1994
Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survivalC M Ballantyne, E A Mainolfi, J B Young, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) studyYuhree Kim, Kunihiro Matsushita, Yingying Sang, et al.
Journal of the American College of Cardiology|October 11, 1991
Lipoprotein(a) and apolipoprotein changes after cardiac transplantationJ A Farmer, C M Ballantyne, O H Frazier, et al.
Diabetes, Obesity & Metabolism|February 27, 2023
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort studySuzanne V Arnold, James A de Lemos, Luke Zheng, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2024
Ancestrally diverse genome-wide association analysis highlights ancestry-specific differences in genetic regulation of plasma protein levelsChloé Sarnowski, Jianzhong Ma, Ngoc Quynh H Nguyen, et al.
Pageof 100